tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ANAB Stock Latest News

AnaptysBio price target lowered to $56 from $80 at Stifel
The FlyAnaptysBio price target lowered to $56 from $80 at Stifel
3d ago
ANAB
AnaptysBio Files Legal Complaint Against GSK and Tesaro
PremiumCompany Announcements
AnaptysBio Files Legal Complaint Against GSK and Tesaro
17d ago
8K
ANAB
Buy Rating for AnaptysBio Amid Legal Dispute with Tesaro Over Jemperli Rights
PremiumRatings
Buy Rating for AnaptysBio Amid Legal Dispute with Tesaro Over Jemperli Rights
20d ago
ANAB
AnaptysBio Sues TESARO Over License Agreement Breach
PremiumCompany Announcements
AnaptysBio Sues TESARO Over License Agreement Breach
22d ago
8K
ANAB
AnaptysBio Expands Stock Repurchase Plan by $100M
PremiumCompany Announcements
AnaptysBio Expands Stock Repurchase Plan by $100M
22d ago
8K
ANAB
Video: Gap jumps after strong comparable sales growth
PremiumThe FlyVideo: Gap jumps after strong comparable sales growth
22d ago
DT
GAP
Morning Movers: AnaptysBio sinks after GSK sues
Premium
The Fly
Morning Movers: AnaptysBio sinks after GSK sues
22d ago
BJ
GAP
AnaptysBio initiates litigation against GSK subsidiary Tesaro
Premium
The Fly
AnaptysBio initiates litigation against GSK subsidiary Tesaro
23d ago
GSK
ANAB
AnaptysBio announces $100M share repurchase program
PremiumThe Fly
AnaptysBio announces $100M share repurchase program
23d ago
ANAB
GSK subsidiary initiates litigation against AnaptysBio
PremiumThe Fly
GSK subsidiary initiates litigation against AnaptysBio
23d ago
GSK
ANAB
AnaptysBio price target lowered to $52 from $59 at H.C. Wainwright
PremiumThe Fly
AnaptysBio price target lowered to $52 from $59 at H.C. Wainwright
1M ago
ANAB
AnaptysBio price target lowered to $70 from $83 at Barclays
PremiumThe Fly
AnaptysBio price target lowered to $70 from $83 at Barclays
1M ago
ANAB
AnaptysBio price target lowered to $50 from $70 at Wedbush
PremiumThe FlyAnaptysBio price target lowered to $50 from $70 at Wedbush
1M ago
ANAB
AnaptysBio price target raised to $36 from $20 at Truist
Premium
The Fly
AnaptysBio price target raised to $36 from $20 at Truist
1M ago
ANAB
VNDA
AnaptysBio trading resumes
Premium
The Fly
AnaptysBio trading resumes
1M ago
ANAB
AnaptysBio: Phase 2 rosnilimab trial did not meet primary, secondary endpoints
PremiumThe Fly
AnaptysBio: Phase 2 rosnilimab trial did not meet primary, secondary endpoints
1M ago
ANAB
AnaptysBio trading halted, news pending
PremiumThe Fly
AnaptysBio trading halted, news pending
1M ago
ANAB
AnaptysBio’s Strategic Split and Robust Pipeline Justify Buy Rating
PremiumRatings
AnaptysBio’s Strategic Split and Robust Pipeline Justify Buy Rating
1M ago
ANAB
AnaptysBio Reports Q3 2025 Results and Strategic Plans
PremiumCompany Announcements
AnaptysBio Reports Q3 2025 Results and Strategic Plans
1M ago
ANAB
AnaptysBio’s Strategic Split and Promising Clinical Developments Drive Buy Rating
PremiumRatingsAnaptysBio’s Strategic Split and Promising Clinical Developments Drive Buy Rating
1M ago
ANAB
AnaptysBio reports Q3 EPS 52c vs ($1.14) last year
Premium
The Fly
AnaptysBio reports Q3 EPS 52c vs ($1.14) last year
1M ago
ANAB
AnaptysBio announces Phase 2b trial results for rosnilimab in RA
Premium
The Fly
AnaptysBio announces Phase 2b trial results for rosnilimab in RA
2M ago
ANAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >